Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-08-19

Clinical Trial Update: Peri-Incisional Drug Injection in Lumbar Spine Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating peri-incisional drug injection in lumbar spine surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: Lumbar Disc Herniation, Degenerative Disc Disease | Phase 3 | Status: WITHDRAWN